Skip to main content
MedPathMedPath Home
Clinical Trials/ACTRN12610000068066
ACTRN12610000068066
Completed
Phase 1

A phase 1 study to assess the safety of mesenchymal stromal cells to treat steroid-refractory graft versus host disease after allogeneic haemopoietic stem cell tranplantation.

R.P.Herrmann0 sites20 target enrollmentJanuary 20, 2010
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsGraft Versus Host DiseaseInflammatory and Immune System - Other inflammatory or immune system disordersBlood - Haematological diseases

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Graft Versus Host Disease
Sponsor
R.P.Herrmann
Enrollment
20
Status
Completed
Last Updated
6 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 20, 2010
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
R.P.Herrmann

Eligibility Criteria

Inclusion Criteria

  • •Steroid\-refractory graft versus host disease post allogeneic haemopoietic stem cell transplant
  • •Informed consent given

Exclusion Criteria

  • •No informed consent

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Phase 1
Comparison of the efficacy of mesenchymal stem cells condition medium injection and ow level laser in the treatment of alopecia
IRCT20200127046282N27Shahid Beheshti University of Medical Sciences30
Recruiting
Phase 1
Evaluation of the safety and effectiveness of mesenchymal stem cells conditioned medium in the treatment of hair lossHair loss.Nonscarring hair loss, unspecifiedL65.9
IRCT20200127046282N13Tehran University of Medical Sciences45
Completed
Not Applicable
Evaluation of safety and tolerability of mesenchymal stem cell mobilization factor KOI2 (Phase 1 study )Epidermolysis bullosa
JPRN-UMIN000018252Osaka University Hospital48
Not yet recruiting
Phase 1
A safety study of autologous mesenchymal precursor cells (MPCs) in the management of delayed healing tibial fractures requiring secondary surgical intervention to promote fracture union.Delayed or non-union tibial fractureMusculoskeletal - Fractures
ACTRN12605000051640Mesoblast10
Active, not recruiting
Phase 1
A prospective phase I/II study to evaluate the use of mesenchymal stromal (stem) cells for the treatment of skin disease in adults with recessive dystrophic epidermolysis bullosaRecessive dystrophic epidermolysis bullosaTherapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17]
EUCTR2014-004500-30-GBKing's College London10